HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

p57(KIP2) control of actin cytoskeleton dynamics is responsible for its mitochondrial pro-apoptotic effect.

Abstract
p57 (Kip2, cyclin-dependent kinase inhibitor 1C), often found downregulated in cancer, is reported to hold tumor suppressor properties. Originally described as a cyclin-dependent kinase (cdk) inhibitor, p57(KIP2) has since been shown to influence other cellular processes, beyond cell cycle regulation, including cell death and cell migration. Inhibition of cell migration by p57(KIP2) is attributed to the stabilization of the actin cytoskeleton through the activation of LIM domain kinase-1 (LIMK-1). Furthermore, p57(KIP2) is able to enhance mitochondrial-mediated apoptosis. Here, we report that the cell death promoting effect of p57(KIP2) is linked to its effect on the actin cytoskeleton. Indeed, whereas Jasplakinolide, an actin cytoskeleton-stabilizing agent, mimicked p57(KIP2)'s pro-apoptotic effect, destabilizing the actin cytoskeleton with cytochalsin D reversed p57(KIP2)'s pro-apoptotic function. Conversely, LIMK-1, the enzyme mediating p57(KIP2)'s effect on the actin cytoskeleton, was required for p57(KIP2)'s death promoting effect. Finally, p57(KIP2-)mediated stabilization of the actin cytoskeleton was associated with the displacement of hexokinase-1, an inhibitor of the mitochondrial voltage-dependent anion channel, from the mitochondria, providing a possible mechanism for the promotion of the mitochondrial apoptotic cell death pathway. Altogether, our findings link together two tumor suppressor properties of p57(KIP2), by showing that the promotion of cell death by p57(KIP2) requires its actin cytoskeleton stabilization function.
AuthorsE Kavanagh, P Vlachos, V Emourgeon, J Rodhe, B Joseph
JournalCell death & disease (Cell Death Dis) Vol. 3 Pg. e311 (May 17 2012) ISSN: 2041-4889 [Electronic] England
PMID22592318 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CDKN1C protein, human
  • Cyclin-Dependent Kinase Inhibitor p57
  • Depsipeptides
  • jasplakinolide
  • Cytochalasin D
  • Voltage-Dependent Anion Channel 1
  • HK1 protein, human
  • Hexokinase
  • LIMK1 protein, human
  • Lim Kinases
  • Staurosporine
Topics
  • Actin Cytoskeleton (drug effects)
  • Apoptosis (drug effects)
  • Cell Movement
  • Cyclin-Dependent Kinase Inhibitor p57 (metabolism)
  • Cytochalasin D (pharmacology)
  • Depsipeptides (pharmacology)
  • HeLa Cells
  • Hexokinase (antagonists & inhibitors, metabolism)
  • Humans
  • Lim Kinases (metabolism)
  • Mitochondria (metabolism)
  • Staurosporine (pharmacology)
  • Voltage-Dependent Anion Channel 1 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: